ArticleJournal for immunotherapy of cancer2023

Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors.

Anthony W Tolcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.